Literature DB >> 20201989

Optimal stimulation for CD70 induction on human monocyte-derived dendritic cells and the importance of CD70 in naive CD4(+) T-cell differentiation.

Kazue Arimoto-Miyamoto1, Norimitsu Kadowaki, Toshio Kitawaki, Satoshi Iwata, Chikao Morimoto, Takashi Uchiyama.   

Abstract

Studies in mice have shown that CD70 on dendritic cells (DCs) is sufficient to convert T-cell tolerance into immunity and hence induce anti-tumour immune responses. Therefore, it is important to investigate (i) optimal stimuli to induce CD70 on human monocyte-derived DCs (MoDCs), which are widely used for tumour immunotherapy, and (ii) the role of CD70 in functional differentiation of naive CD4(+) and CD8(+) T cells stimulated with MoDCs. We show that interferon-alpha (IFN-alpha) is a key cytokine to differentiate monocytes into DCs with the capacity to express CD70 upon maturation. CD70 expression on IFN-alpha-induced MoDCs was elicited by different categories of maturation-inducing factors (Toll-like receptor ligands, CD40 ligand and pro-inflammatory mediators), among which prostaglandin E(2) was most effective. Naive T cells stimulated with MoDCs also expressed CD70. Stimulation with MoDCs promoted naive CD4(+) T cells to acquire the ability to produce T helper type 1 and 2 cytokines in a CD70-dependent manner. In contrast, the CD70-CD27 interaction diminished the production of an immunoregulatory cytokine IL-10. The CD27 signal did not play a dominant role in the induction of effector molecules in naive CD8(+) T cells during the stimulation with MoDCs. This study adds a novel function to the versatile cytokines, type I IFNs, that is, the induction of CD70 on MoDCs. CD70 promotes naive CD4(+) T cells to acquire immunostimulatory activity through the DC-T-cell and T-cell-T-cell interactions during the stimulation with MoDCs. Hence, the CD70-CD27 interaction may play an important role in inducing effective immune responses in DC-based immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20201989      PMCID: PMC2855801          DOI: 10.1111/j.1365-2567.2010.03220.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  30 in total

1.  Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors.

Authors:  Marc Dauer; Bianca Obermaier; Jan Herten; Carola Haerle; Katrin Pohl; Simon Rothenfusser; Max Schnurr; Stefan Endres; Andreas Eigler
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

2.  TNF skews monocyte differentiation from macrophages to dendritic cells.

Authors:  Pascale Chomarat; Carole Dantin; Lynda Bennett; Jacques Banchereau; A Karolina Palucka
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

3.  Rapid high efficiency sensitization of CD8+ T cells to tumor antigens by dendritic cells leads to enhanced functional avidity and direct tumor recognition through an IL-12-dependent mechanism.

Authors:  Shuwen Xu; Gary K Koski; Mark Faries; Isabelle Bedrosian; Rosemarie Mick; Markus Maeurer; Martin A Cheever; Peter A Cohen; Brian J Czerniecki
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

4.  Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion.

Authors:  R Arens; K Tesselaar; P A Baars; G M van Schijndel; J Hendriks; S T Pals; P Krimpenfort; J Borst; M H van Oers; R A van Lier
Journal:  Immunity       Date:  2001-11       Impact factor: 31.745

5.  Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets.

Authors:  Thomas Luft; Michael Jefford; Petra Luetjens; Tracey Toy; Hubertus Hochrein; Kelly-Anne Masterman; Charlie Maliszewski; Ken Shortman; Jonathan Cebon; Eugene Maraskovsky
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

6.  Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells.

Authors:  Elke Scandella; Ying Men; Silke Gillessen; Reinhold Förster; Marcus Groettrup
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

7.  The CD70-CD27 interaction during the stimulation with dendritic cells promotes naive CD4(+) T cells to develop into T cells producing a broad array of immunostimulatory cytokines in humans.

Authors:  Mutsumi Hashimoto-Okada; Toshio Kitawaki; Norimitsu Kadowaki; Satoshi Iwata; Chikao Morimoto; Toshiyuki Hori; Takashi Uchiyama
Journal:  Int Immunol       Date:  2009-06-25       Impact factor: 4.823

8.  Distinct cytokine profiles of neonatal natural killer T cells after expansion with subsets of dendritic cells.

Authors:  N Kadowaki; S Antonenko; S Ho; M C Rissoan; V Soumelis; S A Porcelli; L L Lanier; Y J Liu
Journal:  J Exp Med       Date:  2001-05-21       Impact factor: 14.307

9.  Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice.

Authors:  S M Santini; C Lapenta; M Logozzi; S Parlato; M Spada; T Di Pucchio; F Belardelli
Journal:  J Exp Med       Date:  2000-05-15       Impact factor: 14.307

10.  Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells.

Authors:  M Mohamadzadeh; F Berard; G Essert; C Chalouni; B Pulendran; J Davoust; G Bridges; A K Palucka; J Banchereau
Journal:  J Exp Med       Date:  2001-10-01       Impact factor: 14.307

View more
  7 in total

1.  Interferon gamma licensing of human dendritic cells in T-helper-independent CD8+ alloimmunity.

Authors:  Roxane Lemoine; Florence Velge-Roussel; Florence Herr; Romain Felix; Hubert Nivet; Yvon Lebranchu; Christophe Baron
Journal:  Blood       Date:  2010-07-19       Impact factor: 22.113

2.  Red blood cell alloimmunization is influenced by the delay between Toll-like receptor agonist injection and transfusion.

Authors:  Rahma Elayeb; Marie Tamagne; Philippe Bierling; France Noizat-Pirenne; Benoît Vingert
Journal:  Haematologica       Date:  2015-10-01       Impact factor: 9.941

3.  Reduced naive CD4 T cell numbers and impaired induction of CD27 in response to T cell receptor stimulation reflect a state of immune activation in chronic hepatitis C virus infection.

Authors:  Nicole L Yonkers; Scott Sieg; Benigno Rodriguez; Donald D Anthony
Journal:  J Infect Dis       Date:  2011-01-10       Impact factor: 5.226

Review 4.  Overlapping, additive and counterregulatory effects of type II and I interferons on myeloid dendritic cell functions.

Authors:  Loredana Frasca; Roberto Lande
Journal:  ScientificWorldJournal       Date:  2011-11-01

Review 5.  Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system.

Authors:  Ilse Van Brussel; Zwi N Berneman; Nathalie Cools
Journal:  Mediators Inflamm       Date:  2012-07-18       Impact factor: 4.711

Review 6.  The dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.

Authors:  Barbara Seliger; Chiara Massa
Journal:  Front Immunol       Date:  2013-12-02       Impact factor: 7.561

Review 7.  The Role of Long-Chain Fatty Acids in Inflammatory Bowel Disease.

Authors:  Chunxiang Ma; Reshma Vasu; Hu Zhang
Journal:  Mediators Inflamm       Date:  2019-11-03       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.